ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,633Medicare Part D Prescriptions Filled, Including Refills

Rank: 347 out of 1456

$885K Total Retail Price of All Prescriptions

Rank: 148 out of 1456

533 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,730 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 364 345 1 2
ZOLPIDEM TARTRATE 328 300 2 14
LEVOTHYROXINE SODIUM 285 256 3 4
CRESTOR 283 278 4 26
METOPROLOL SUCCINATE 226 208 5 19
DICLOFENAC SODIUM 222 217 6 95
HYDROCODONE-ACETAMINOPHEN 219 173 S3 7 6
ATORVASTATIN CALCIUM 217 209 8 11
AMLODIPINE BESYLATE 217 198 8 1
OMEPRAZOLE 207 191 10 5
SPIRONOLACTONE 201 180 11 73
TRIAMTERENE-HCTZ 200 189 12 49
SYNTHROID 191 163 13 37
DIOVAN HCT 189 178 14 59
METHYLPREDNISOLONE 152 137 15 106
NEXIUM 142 121 16 23
FUROSEMIDE 140 128 17 7
GABAPENTIN 139 122 18 13
CYMBALTA 135 111 19 52
LISINOPRIL 135 127 19 3
CITALOPRAM HBR 132 123 21 22
BYSTOLIC 132 130 21 102
METFORMIN HCL ER 129 120 23 54
POTASSIUM CHLORIDE 123 118 24 15
DIOVAN 123 119 24 35
LOSARTAN-HYDROCHLOROTHIAZIDE 115 98 26 41
HYDROCHLOROTHIAZIDE 113 107 27 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 109 105 28 24
METFORMIN HCL 104 93 29 8
DEXILANT 98 98 30 169
CELEBREX 91 91 31 88
PRAVASTATIN SODIUM 80 79 32 9
METOPROLOL TARTRATE 79 73 33 12
ALLOPURINOL 78 71 34 31
LOSARTAN POTASSIUM 76 73 35 16
FLUTICASONE PROPIONATE 75 73 36 28
BYETTA 75 65 36 281
DONEPEZIL HCL 75 75 36 29
MELOXICAM 71 69 39 30
ATENOLOL 69 68 40 18
BENICAR HCT 68 65 41 160
TRAMADOL HCL 67 60 42 17
PAROXETINE HCL 67 65 42 67
CEFDINIR 67 60 42 216
LIPITOR 65 65 45 76
VICTOZA 3-PAK 65 64 45 337
GLIPIZIDE XL 65 65 45 134
BISOPROLOL-HYDROCHLOROTHIAZIDE 62 58 48 93
SERTRALINE HCL 59 52 49 25
TAMSULOSIN HCL 57 49 50 34
ZETIA 56 51 51 71
SINGULAIR 55 49 52 83
AMLODIPINE BESYLATE-BENAZEPRIL 55 55 52 61
SPIRIVA 53 48 54 75
WARFARIN SODIUM 52 48 55 21
PREDNISONE 51 40 56 42
PROPRANOLOL HCL 51 51 56 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.